ecteinascidin 743 has been researched along with Carcinoma, Non-Small Cell Lung in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, D; Gao, Z; Lin, C; Lin, Y; Liu, H; Liu, SL; Luo, L; Ma, W; Shi, Y; Wang, J; Wang, P; Wang, W; Xiang, Q; Xu, W; Zeng, Z; Zhao, Y | 1 |
| Cai, S; Ding, Z; Liu, X; Zeng, J | 1 |
| Capri, G; Corradino, I; Cresta, S; D'Incalci, M; De Braud, F; Gallerani, E; Gianni, L; Locatelli, A; Marsoni, S; Minoia, C; Noberasco, C; Sessa, C; Zintl, P; Zucchetti, M | 1 |
| Alberola, V; Alfaro, V; Camps, C; Cobo, M; Dómine, M; Gutiérrez-Calderón, V; Isla, D; Lardelli, P; Massuti, B; Nieto, A; Provencio, M; Rosell, R; Tarón, M; Viñolas, N | 1 |
| Beijnen, JH; Beumer, JH; Lopez-Lazaro, L; Rademaker-Lakhai, JM; Rosing, H; Schellens, JH | 1 |
| Faircloth, GT; Fiebig, HH; Giavazzi, R; Hendriks, HR; Jimeno, JM; Langdon, SP | 1 |
1 review(s) available for ecteinascidin 743 and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Trabectedin in Cancers: Mechanisms and Clinical Applications.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Dioxoles; Humans; Lung Neoplasms; Sarcoma; Trabectedin; Tumor Microenvironment | 2022 |
3 trial(s) available for ecteinascidin 743 and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dioxoles; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Neutropenia; Ovarian Neoplasms; Tetrahydroisoquinolines; Trabectedin | 2009 |
Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; Dioxoles; DNA-Binding Proteins; Endonucleases; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nuclear Proteins; Platinum; Tetrahydroisoquinolines; Trabectedin; Transcription Factors; Treatment Outcome | 2012 |
Trabectedin (Yondelis, formerly ET-743), a mass balance study in patients with advanced cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Dioxoles; Feces; Female; Half-Life; Humans; Isoquinolines; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma; Sarcoma, Synovial; Tetrahydroisoquinolines; Trabectedin | 2005 |
2 other study(ies) available for ecteinascidin 743 and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Trabectedin induces ferroptosis via regulation of HIF-1α/IRP1/TFR1 and Keap1/Nrf2/GPX4 axis in non-small cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Ferroptosis; Humans; Iron; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; NF-E2-Related Factor 2; Reactive Oxygen Species; Trabectedin | 2023 |
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer.
Topics: Adult; Animals; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Dioxoles; Female; Humans; Isoquinolines; Lung Neoplasms; Male; Melanoma; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Ovarian Neoplasms; Tetrahydroisoquinolines; Trabectedin | 1999 |